@article{a7805bed2e3c4de786caae39bb8f44a5,
title = "{"}Low-dose{"} recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage.",
author = "Harrison, \{T Daniel\} and Jason Laskosky and Omid Jazaeri and Pasquale, \{Michael D.\} and Mark Cipolle",
note = "Background: This study was designed to compare mortality and blood product use in patients who received recombinant activated factor VII (rFVIIa) for traumatic hemorrhage to a matched historic control. Methods: Trauma registry data of bleeding trauma patients who received rFVIIa (40 microg/kg, repeated once if needed) included 28-day mortality; pre- and post-rFVIIa international normalized ratio; and packed red blood cell (PRBC), fresh frozen plasma, platelet, and cryoprecipitate requirements.",
year = "2005",
month = jul,
day = "1",
doi = "10.1097/01.TA.0000171470.39742.8E",
language = "American English",
volume = "59",
journal = "Journal of Trauma-injury Infection and Critical Care",
number = "1",
}